Clinical Microbial Testing and Analysis of Resistance Testing of Various Bacteria to Different Drugs
Objective To analyze the results of clinical microbial examination and bacterial drug resistance detection.Methods From January 2023 to March 2023,a total of 691 samples of common bacteria and fungi culture were selected from Sanming Second Hospital,and 221 strains of pathogens were obtained after the same source was excluded.The source and distribution of 221 strains of pathogenic bacteria were analyzed,and the drug resistance detection results were statistically analyzed.Results The main source of 221 isolates was respiratory tract (30.78％).Secretions followed,accounting for 21.72％.The main types of 221 isolates were enterobacteriaceae (39.37％).Next was non-fermentative bacteria,accounting for 23.08％.Pseudomonas aeruginosa has high resistance to tigecycline,amikacin,ceftriaxone,and levofloxacin.Klebsiella pneumoniae has the highest resistance to tetracycline,at 100％,and relatively high resistance to amikacin,ceftazidime,cefepime,ceftriaxone,meropenem,gentamicin,and ertapenem;Escherichia coli has the highest resistance to ampicillin,cefaclor,and cefuroxime,accounting for 100％,while it has higher resistance to amikacin,ceftriaxone,gentamicin,imipenem,and ertapenem;Haemophilus influenzae has the highest resistance to ceftriaxone,levofloxacin,meropenem,ampicillin,cefaclor,and cefuroxime,all at 100％;Acinetobacter baumannii has the highest resistance to tetracycline,at 100％;Staphylococcus aureus has the highest resistance to amikacin,tetracycline,erythromycin,and penicillin,all at 100％.Conclusion The drug resistance of bacteria is relatively high,so strengthening the inspection of clinical microorganisms and monitoring of bacterial drug resistance plays an important role in controlling nosocomial infection.
万方数据
维普
